STOCK TITAN

[Form 4] Health In Tech, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Tim Johnson, the Chief Executive Officer, Director and 10% owner of Health In Tech, Inc. (HIT), was granted 34,000 restricted shares of Class A Common Stock on 08/15/2025. The shares were granted at $0 and are subject to performance-based vesting tied to the successful launch and full operation of two specified company programs: 50% vest monthly over 12 months after the first program is launched and operational, and the remaining 50% vest monthly over 12 months after the second program is launched and operational. After this grant the reporting person beneficially owns 22,469,741 shares, which the filing clarifies includes 62,193 restricted shares and 22,407,548 Class A shares and expressly excludes 9,000,000 Class B shares and 734,707 options to purchase Class A shares.

Tim Johnson, Amministratore Delegato, Direttore e detentore del 10% di Health In Tech, Inc. (HIT), ha ricevuto in data 15/08/2025 34.000 azioni vincolate di Classe A Common Stock. Le azioni sono state assegnate a $0 e sono soggette a condizioni di maturazione basate sulle prestazioni, collegate al lancio con successo e al pieno funzionamento di due programmi aziendali specificati: il 50% matura mensilmente nell’arco di 12 mesi dopo che il primo programma è stato lanciato e operativo, e il restante 50% matura mensilmente nell’arco di 12 mesi dopo che il secondo programma è stato lanciato e operativo. Dopo questa assegnazione la persona che presenta la comunicazione possiede utilmente 22.469.741 azioni; il deposito chiarisce che tale totale include 62.193 azioni vincolate e 22.407.548 azioni di Classe A ed esclude espressamente 9.000.000 di azioni di Classe B e 734.707 opzioni per l’acquisto di azioni di Classe A.

Tim Johnson, Director Ejecutivo, miembro del Consejo y propietario del 10% de Health In Tech, Inc. (HIT), recibió el 15/08/2025 34.000 acciones restringidas de Clase A Common Stock. Las acciones se concedieron a $0 y están sujetas a un vencimiento condicionado al rendimiento ligado al lanzamiento exitoso y la plena operación de dos programas específicos de la compañía: el 50% vence mensualmente durante 12 meses tras la puesta en marcha y operatividad del primer programa, y el 50% restante vence mensualmente durante 12 meses tras la puesta en marcha y operatividad del segundo programa. Tras esta concesión, la persona que presenta el informe posee de forma beneficiaria 22.469.741 acciones; la presentación aclara que esto incluye 62.193 acciones restringidas y 22.407.548 acciones de Clase A, y excluye expresamente 9.000.000 de acciones de Clase B y 734.707 opciones para comprar acciones de Clase A.

팀 존슨은 Health In Tech, Inc.(HIT)의 최고경영자(CEO), 이사 및 10% 지분 보유자로서 2025년 8월 15일에 클래스 A 보통주 34,000주의 제한주를 부여받았습니다. 해당 주식은 $0로 부여되었으며, 두 개의 특정 회사 프로그램이 성공적으로 출시되어 완전히 운영되는 것에 연동되는 성과 기반 베스팅 조건이 적용됩니다: 첫 번째 프로그램이 출시되어 운영된 이후 12개월 동안 매월 50%가 베스트되고, 두 번째 프로그램이 출시되어 운영된 이후 12개월 동안 나머지 50%가 매월 베스트됩니다. 이 부여 이후 신고인(보고자)은 실질적으로 22,469,741주를 보유하고 있으며, 제출서류는 이 수치에 62,193주의 제한주와 22,407,548주의 클래스 A 주식이 포함되고, 9,000,000주의 클래스 B 주식과 734,707주의 클래스 A 매수옵션은 명시적으로 제외된다고 밝히고 있습니다.

Tim Johnson, Directeur général (CEO), administrateur et détenteur de 10% de Health In Tech, Inc. (HIT), s'est vu attribuer 34 000 actions restreintes de Classe A Common Stock le 15/08/2025. Les actions ont été accordées à $0 et sont soumises à un vesting basé sur la performance, lié au lancement réussi et à la mise en pleine opération de deux programmes spécifiques de la société : 50% acquièrent des droits mensuellement sur 12 mois après que le premier programme ait été lancé et soit opérationnel, et les 50% restants acquièrent des droits mensuellement sur 12 mois après que le second programme ait été lancé et soit opérationnel. Après cette attribution, la personne déclarée possède au bénéfice 22 469 741 actions ; le dépôt précise que ce total inclut 62 193 actions restreintes et 22 407 548 actions de Classe A et exclut expressément 9 000 000 d’actions de Classe B ainsi que 734 707 options d’achat d’actions de Classe A.

Tim Johnson, Chief Executive Officer, Direktor und 10%-Eigentümer von Health In Tech, Inc. (HIT), wurde am 15.08.2025 34.000 eingeschränkte Aktien der Klasse A (Common Stock) gewährt. Die Aktien wurden zu $0 zugeteilt und unterliegen einer leistungsbezogenen Vesting-Regelung, die an den erfolgreichen Start und den vollständigen Betrieb von zwei festgelegten Unternehmensprogrammen gekoppelt ist: 50% vesten monatlich über 12 Monate, nachdem das erste Programm gestartet und in Betrieb genommen wurde, und die restlichen 50% vesten monatlich über 12 Monate, nachdem das zweite Programm gestartet und in Betrieb genommen wurde. Nach dieser Zuteilung besitzt die meldende Person wirtschaftlich 22.469.741 Aktien; die Einreichung stellt klar, dass dies 62.193 eingeschränkte Aktien und 22.407.548 Klasse-A-Aktien umfasst und ausdrücklich 9.000.000 Klasse-B-Aktien sowie 734.707 Optionen zum Kauf von Klasse-A-Aktien ausschließt.

Positive
  • Performance-based vesting ties the restricted stock grant to the successful launch and full operation of two specified company programs
  • Granted shares at $0 are restricted rather than immediately sold, aligning CEO incentives with company milestones
Negative
  • Beneficial ownership reporting excludes 9,000,000 Class B shares and 734,707 options, which may complicate simple Class A ownership interpretation
  • Vesting contingent on future events means the shares are not presently vested and depend on unspecified program launch timing

Insights

TL;DR: CEO received a performance-vested grant of 34,000 restricted Class A shares tied to product launches, modest relative to total holdings.

The grant is structured as restricted stock with vesting contingent on two specified programs becoming launched and fully operational. This design aligns management incentives with operational milestones rather than immediate cash compensation. The reported post-grant beneficial ownership totals 22,469,741 shares, with the filing explicitly separating Class A, Class B, restricted shares and options. Given the size of the grant relative to total reported holdings, the immediate dilution or change in control economics appears limited based on the disclosed numbers.

TL;DR: Grant ties executive compensation to operational milestones, reflecting governance focus on performance-based incentives.

The restricted share award vests only upon achievement of defined operational milestones, which is a governance mechanism to link pay to performance. The filing discloses the composition of the reporting person's holdings and explicitly excludes substantial Class B shares and outstanding options from the Class A beneficial ownership count, providing clarity on capital structure components relevant to control and voting discussions.

Tim Johnson, Amministratore Delegato, Direttore e detentore del 10% di Health In Tech, Inc. (HIT), ha ricevuto in data 15/08/2025 34.000 azioni vincolate di Classe A Common Stock. Le azioni sono state assegnate a $0 e sono soggette a condizioni di maturazione basate sulle prestazioni, collegate al lancio con successo e al pieno funzionamento di due programmi aziendali specificati: il 50% matura mensilmente nell’arco di 12 mesi dopo che il primo programma è stato lanciato e operativo, e il restante 50% matura mensilmente nell’arco di 12 mesi dopo che il secondo programma è stato lanciato e operativo. Dopo questa assegnazione la persona che presenta la comunicazione possiede utilmente 22.469.741 azioni; il deposito chiarisce che tale totale include 62.193 azioni vincolate e 22.407.548 azioni di Classe A ed esclude espressamente 9.000.000 di azioni di Classe B e 734.707 opzioni per l’acquisto di azioni di Classe A.

Tim Johnson, Director Ejecutivo, miembro del Consejo y propietario del 10% de Health In Tech, Inc. (HIT), recibió el 15/08/2025 34.000 acciones restringidas de Clase A Common Stock. Las acciones se concedieron a $0 y están sujetas a un vencimiento condicionado al rendimiento ligado al lanzamiento exitoso y la plena operación de dos programas específicos de la compañía: el 50% vence mensualmente durante 12 meses tras la puesta en marcha y operatividad del primer programa, y el 50% restante vence mensualmente durante 12 meses tras la puesta en marcha y operatividad del segundo programa. Tras esta concesión, la persona que presenta el informe posee de forma beneficiaria 22.469.741 acciones; la presentación aclara que esto incluye 62.193 acciones restringidas y 22.407.548 acciones de Clase A, y excluye expresamente 9.000.000 de acciones de Clase B y 734.707 opciones para comprar acciones de Clase A.

팀 존슨은 Health In Tech, Inc.(HIT)의 최고경영자(CEO), 이사 및 10% 지분 보유자로서 2025년 8월 15일에 클래스 A 보통주 34,000주의 제한주를 부여받았습니다. 해당 주식은 $0로 부여되었으며, 두 개의 특정 회사 프로그램이 성공적으로 출시되어 완전히 운영되는 것에 연동되는 성과 기반 베스팅 조건이 적용됩니다: 첫 번째 프로그램이 출시되어 운영된 이후 12개월 동안 매월 50%가 베스트되고, 두 번째 프로그램이 출시되어 운영된 이후 12개월 동안 나머지 50%가 매월 베스트됩니다. 이 부여 이후 신고인(보고자)은 실질적으로 22,469,741주를 보유하고 있으며, 제출서류는 이 수치에 62,193주의 제한주와 22,407,548주의 클래스 A 주식이 포함되고, 9,000,000주의 클래스 B 주식과 734,707주의 클래스 A 매수옵션은 명시적으로 제외된다고 밝히고 있습니다.

Tim Johnson, Directeur général (CEO), administrateur et détenteur de 10% de Health In Tech, Inc. (HIT), s'est vu attribuer 34 000 actions restreintes de Classe A Common Stock le 15/08/2025. Les actions ont été accordées à $0 et sont soumises à un vesting basé sur la performance, lié au lancement réussi et à la mise en pleine opération de deux programmes spécifiques de la société : 50% acquièrent des droits mensuellement sur 12 mois après que le premier programme ait été lancé et soit opérationnel, et les 50% restants acquièrent des droits mensuellement sur 12 mois après que le second programme ait été lancé et soit opérationnel. Après cette attribution, la personne déclarée possède au bénéfice 22 469 741 actions ; le dépôt précise que ce total inclut 62 193 actions restreintes et 22 407 548 actions de Classe A et exclut expressément 9 000 000 d’actions de Classe B ainsi que 734 707 options d’achat d’actions de Classe A.

Tim Johnson, Chief Executive Officer, Direktor und 10%-Eigentümer von Health In Tech, Inc. (HIT), wurde am 15.08.2025 34.000 eingeschränkte Aktien der Klasse A (Common Stock) gewährt. Die Aktien wurden zu $0 zugeteilt und unterliegen einer leistungsbezogenen Vesting-Regelung, die an den erfolgreichen Start und den vollständigen Betrieb von zwei festgelegten Unternehmensprogrammen gekoppelt ist: 50% vesten monatlich über 12 Monate, nachdem das erste Programm gestartet und in Betrieb genommen wurde, und die restlichen 50% vesten monatlich über 12 Monate, nachdem das zweite Programm gestartet und in Betrieb genommen wurde. Nach dieser Zuteilung besitzt die meldende Person wirtschaftlich 22.469.741 Aktien; die Einreichung stellt klar, dass dies 62.193 eingeschränkte Aktien und 22.407.548 Klasse-A-Aktien umfasst und ausdrücklich 9.000.000 Klasse-B-Aktien sowie 734.707 Optionen zum Kauf von Klasse-A-Aktien ausschließt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Johnson Tim Donald

(Last) (First) (Middle)
701 S. COLORADO AVE,
SUITE 1

(Street)
STUART FL 34994

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 08/15/2025 A 34,000(1) A $0 22,469,741(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. Fifty percent (50%) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the first of two specified programs being developed by the Company is successfully launched and fully operational in the marketplace, and the remaining fifty percent (50%) shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the other specified program being developed by the Company is successfully launched and fully operational in the marketplace.
2. Includes 62,193 shares of restricted stock and 22,407,548 shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.
/s/ Tim Johnson 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Tim Johnson report on Form 4 for HIT?

The report discloses a grant of 34,000 restricted shares of Class A Common Stock to Tim Johnson on 08/15/2025.

How do the restricted shares vest for the CEO in HIT's Form 4?

Fifty percent of the restricted shares vest in equal monthly installments over 12 months after the first specified program is launched and fully operational; the remaining 50% vest similarly after the second program is launched and fully operational.

What is Tim Johnson's beneficial ownership after the reported transaction?

The filing reports 22,469,741 shares beneficially owned following the transaction, including 62,193 restricted shares and 22,407,548 Class A shares.

Are there other equity interests excluded from the reported Class A beneficial ownership?

Yes. The filing explicitly excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase Class A Common Stock from the reported Class A beneficial ownership total.

Was there a purchase price reported for the granted restricted shares?

The transaction is reported with a price of $0, indicating these were granted restricted shares rather than a paid purchase.
Health In Tech, Inc.

NASDAQ:HIT

HIT Rankings

HIT Latest News

HIT Latest SEC Filings

HIT Stock Data

186.08M
13.35M
70.13%
0.86%
0.26%
Software - Application
Insurance Agents, Brokers & Service
Link
United States
STUART